Phase I expansion cohort results of cemiplimab, a human PD-1 monoclonal antibody, in combination with radiotherapy (RT), cyclophosphamide and GM-CSF, in patients (pts) with recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC)

H. M. Babiker, I. Brana, D. Mahadevan, T. K. Owonikoko, E. Calvo, D. Rischin, V. Moreno, K. P. Papadopoulos, M. Crittenden, S. Formenti, J. Giralt, P. Garrido Lopez, A. Hervás Morón, K. K. Mohan, M. G. Fury, I. Lowy, E. Stankevich, M. Feng, J. Li, M. Mathias

Research output: Contribution to journalArticlepeer-review

80 Scopus citations
Original languageEnglish (US)
Pages (from-to)viii418
JournalAnnals of oncology : official journal of the European Society for Medical Oncology
Volume29
DOIs
StatePublished - Oct 1 2018

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this